GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito

Risk Stratification and Screening for Early Onset Colorectal Cancer

Fight Colorectal Cancer

J. Demb, F. May, A. Zauber, I. Lansdorp-Vogelaar, A. Shaukat, J. Perea Garcia, H. Hampel

Personalized MRD Assessment and Treatment Decision-Making in CRC: Up…

UChicago Medicine

B. Polite

Organ Preservation in Rectal Cancer: Neoadjuvant Short-Course RT vs.…

Memorial Sloan Kettering Cancer Center

P. Romesser

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

Using ctDNA to Guide Adjuvant Therapy in GI Malignancies

University of Miami Sylvester Comprehensive Cancer Center

P. Hosein

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

Anal Cancer Staging and Treatment Options

GRACE

P. Romesser